Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Pan Afr Med J ; 35(Suppl 2): 144, 2020.
Article de Anglais | MEDLINE | ID: mdl-33193959

RÉSUMÉ

INTRODUCTION: since the first spread of the novel coronavirus (COVID-19) in Morocco in March 2020, the Moroccan Health System underwent an important pressure and remarkable efforts were spent to provide efficient reactions to this emergency. Public hospitals have set adapted strategies dedicated to overcoming the overload of COVID-19 patients, and our Oncology and Hematology Center (OHC) has implemented a flexible adapted strategy aiming to reduce the burden of COVID-19. We report our single-center experience on the detailed infection control measures undertaken to minimize virus transmission. METHODS: we reviewed all patients treated at the OHC from March 2nd to April 20th, 2020 as measures were taken since the detection of the first COVID-19 case to ensure the protection of patients and healthcare providers, especially a screening zone for any patient entering the center. The patient's data were retrospectively collected and anonymized. RESULTS: we notified a significant decrease in patients' admissions during the lockdown period at the different units of our center. The screening area received a total of 5267 patients during our study period, with an average of 105 patients per day. Interestingly, no healthcare professional was infected and only 8 patients showed symptoms of fever and cough, and all of them had a negative test for COVID-19 (RT-PCR). Thus, the OHC is considered as a COVID-19 free center with zero cases among patients and healthcare providers. CONCLUSION: by having a 0% rate of infection, the efficiency of our measures is proven, but efforts are still needed as we have to measure the impact of this pandemic in our cancer management.


Sujet(s)
Betacoronavirus , Établissements de cancérologie/organisation et administration , Infections à coronavirus/épidémiologie , Tumeurs/thérapie , Pandémies , Pneumopathie virale/épidémiologie , COVID-19 , Dépistage de la COVID-19 , Techniques de laboratoire clinique , Continuité des soins , Infections à coronavirus/diagnostic , Infections à coronavirus/prévention et contrôle , Prise en charge de la maladie , Femelle , Accessibilité des services de santé , Services hospitaliers/statistiques et données numériques , Unités hospitalières/statistiques et données numériques , Humains , Prévention des infections/organisation et administration , Transmission de maladie infectieuse du patient au professionnel de santé/prévention et contrôle , Transmission de maladie infectieuse du professionnel de santé au patient/prévention et contrôle , Mâle , Dépistage de masse/organisation et administration , Adulte d'âge moyen , Maroc , Pandémies/prévention et contrôle , Pneumopathie virale/diagnostic , Pneumopathie virale/prévention et contrôle , Études rétrospectives , SARS-CoV-2
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...